Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

Overview of G6PD Deficiency

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition that affects the red blood cells, leading to hemolytic anemia under specific stress conditions. The deficiency impairs the ability to produce NADPH, which is essential for several cellular functions, including protection against oxidative stress.

Enzymes Associated with G6PD Deficiency

  1. Glucose-6-Phosphate Dehydrogenase (G6PD): This enzyme is critical in the pentose phosphate pathway. It catalyzes the oxidation of glucose-6-phosphate, producing NADPH and 6-phosphogluconolactone.

  2. Glutathione Reductase: This enzyme utilizes NADPH to convert oxidized glutathione (GSSG) back to reduced glutathione (GSH).

  3. Glutathione Peroxidase: This enzyme uses reduced glutathione (GSH) to convert toxic hydrogen peroxide (H₂O₂) into harmless water.

Pathophysiology of G6PD Deficiency

  1. Lowered NADPH Levels: The primary issue in G6PD deficiency is the inability to produce sufficient NADPH, leading to a deficient antioxidative capacity in cells.

    • NADPH is vital for the regeneration of reduced glutathione, a key antioxidant molecule in cells.

  2. Reduced Glutathione Depletion: Low levels of NADPH hinder the activity of glutathione reductase, preventing the conversion of GSSG into GSH.

  3. Failure of Glutathione Peroxidase: Without adequate GSH, glutathione peroxidase cannot effectively neutralize hydrogen peroxide.

  4. Oxidative Damage: The accumulation of hydrogen peroxide leads to oxidative stress within the red blood cells, causing:

    • Oxidation of hemoglobin.
    • Damage to the membrane sulfhydryl groups, leading to structural changes in red blood cells.
    • Formation of Heinz bodies, which are aggregates of denatured hemoglobin.

  5. Hemolytic Anemia: Hemolytic anemia occurs due to:

    • Formation of Heinz bodies making red blood cells rigid.
    • Destruction of these rigid cells by macrophages in the spleen (extravascular hemolysis).
    • Direct breakdown of red blood cells in the bloodstream (intravascular hemolysis).

The Pentose Phosphate Pathway (PPP)

Overview of the Pentose Phosphate Pathway

The pentose phosphate pathway, also known as the hexose monophosphate shunt (HMP shunt), oxidative pathway, or direct oxidative pathway, is a metabolic pathway parallel to glycolysis. This pathway primarily occurs in the cytosol of various tissues, including:

  • Liver
  • Adipose tissue
  • Erythrocytes
  • Neutrophils
  • Adrenal cortex
  • Thyroid
  • Testis
  • Ovaries
  • Lactating mammary gland

The pathway is less active in skeletal muscle.

Key Functions of the Pentose Phosphate Pathway

  1. Production of NADPH: The PPP generates NADPH, which plays critical roles in:

    • Cholesterol synthesis.
    • Fatty acid synthesis.
    • Reduction of oxidized glutathione (GSSG) to GSH, which protects cells from reactive oxygen species (ROS).
    • Detoxification processes, including drug metabolism via cytochrome P450 enzymes.
    • Supporting phagocytosis in immune cells.

  2. Synthesis of Ribose-5-Phosphate: Ribose-5-phosphate is vital for nucleotide synthesis, assisting in the formation of nucleic acids.

Enzymatic Steps in the PPP

  • Oxidative Phase (Irreversible): This phase includes:

    1. Glucose-6-phosphate dehydrogenase (rate-limiting step): converts glucose-6-phosphate into 6-phosphogluconolactone, producing NADPH.
    2. 6-phosphogluconolactonase: hydrolyzes 6-phosphogluconolactone to 6-phosphogluconate.
    3. 6-phosphogluconate dehydrogenase: converts 6-phosphogluconate to ribulose-5-phosphate, producing another molecule of NADPH and releasing CO₂.

  • Non-oxidative Phase (Reversible): This phase allows for the interconversion of sugars and includes:

    • Transketolases and Transaldolases: These enzymes catalyze the conversion of ribulose-5-phosphate to glyceraldehyde-3-phosphate and fructose-6-phosphate, facilitating nucleotide synthesis and providing intermediates for glycolysis.

Medical Significance of the HMP Shunt

The HMP shunt is essential in various clinical conditions. Defects in this pathway can lead to diseases, particularly G6PD deficiency, characterized by:

  • Impaired NADPH generation.
  • Increased susceptibility to oxidative stress, leading to:
    • Hemolytic anemia, particularly during episodes of infection, exposure to certain drugs (like primaquine and sulfonamides), or ingestion of fava beans (favoring a condition known as favism).
  • NADPH plays a crucial role not just in redox balance, but also in cancer cell biology, assisting in the growth and survival of malignant cells.

Summary of Functions of NADPH

  1. Biosynthesis of fatty acids.
  2. Involvement in certain amino acid pathways, notably those mediated by glutamate dehydrogenase.
  3. Participation in antioxidant processes, particularly those mediated by glutathione.
  4. Detoxification of drugs through cytochrome P450 mechanisms.
  5. Role in immune response, especially during phagocytosis.